Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RestoreGut: Microbiome Restoration After Cesarean Section
NCT06264219Phase 1Recruiting
- Sponsor
- Jakob Stokholm
- Start
- Aug 2024
- Primary completion
- Aug 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of allogeneic fecal microbiota and fecal bacteriophage transfer in Microbial Colonization (MC) (4 arms), sponsored by Jakob Stokholm. Primary endpoint: Microbial compositional differences compared with placebo-treated infants at 1 week. Started Aug 2024; status: recruiting.
02
Drugs
allogeneic fecal microbiotafecal bacteriophage transfer
03
Conditions
Microbial Colonization (MC)
Beyond the preview
Go deeper on NCT06264219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06264219.